The new CTR (Clinical Trial Regulation) No 536/2014 will repeal the existing Clinical Trial Directive No 2001/20CE on the 31st of January 2022. It’s impossible to summarize all changes that come along with this new regulation in one sentence, however one major change...
We are thrilled to announce that ExperTrials is the chosen CRO by Scynexis, Inc. for their phase II and by Vanda Pharmaceuticals, Inc. for a pivotal study (phase III).
Meet us on 14-18 June 2021 !
Don’t miss our presentation on 25th of May 2021 for the introduction of ExperTrials as new AFSSI members Feel free to join us and listen to our presentation
Let’s talk about your project
35/37 rue Louis Guérin
+33 (0)4 20 10 62 16